Fibrous dysplasia

Archives of Pathology and Laboratory Medicine

Volumn 137, Issue 1, 2013, Pages 134-138

  Riddle, Nicole D ^a   Bui, Marilyn M ^b  

^a PENNSYLVANIA HOSPITAL   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

FIBROUS DYSPLASIA; GENETICS; HUMAN; MUTATION; PROGNOSIS; REVIEW; WNT SIGNALING PATHWAY;

FIBROUS DYSPLASIA OF BONE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; MUTATION; PROGNOSIS; WNT SIGNALING PATHWAY;

EID: 84872028156     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2012.0013-RS     Document Type: Review

References (29)

1. DiCaprio MR, Enneking WF. Fibrous dysplasia: Pathophysiology, evaluation, and treatment. J Bone Joint Surg Am. 2005;87(8):1848-1864.
2. Fletcher CDM, Unni KK, Mertens F, eds. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; 2002. World Health Organization Classification of Tumours; vol 4.
3. Horvai A, Unni KK. Premalignant conditions of bone. J Orthop Sci. 2006; 11(4):412-423.
4. Albright F, Butter AM, Smith P. Syndrome characterized by posterities fibrosa disseminate, areas of pigmentation and endocrine dysfunction, with precocious puberty in females: Report of five cases. N Engl J Med. 1937;216(17): 727-746.
5. McCune DJ, Bruch H. Osteodystrophia fibrosa: Report of a case in which the condition was combined with precocious puberty, pathologic pigmentation of the skin and hyperthyroidism, a review of the literature. Am J Dis Child. 1937; 54(4):806-848.
6. Zacharin M. The spectrum of McCune Albright syndrome. Pediatr Endocrinol Rev. 2007;4(suppl 4):412-418.
7. Chanson P, Salenave S, Orcel P. McCune-Albright syndrome in adulthood. Pediatr Endocrinol Rev. 2007;4(suppl 4):453-462.
8. Daneman A, Daneman D. McCune-Albright syndrome. J Pediatr Endocrinol Metab. 2007;20(12):1265.
9. Zoccali C, Teori G, Prencipe U, Erba F. Mazabraud's syndrome: A new case and review of the literature. Int Orthop. 2009;33(3):605-610.
10. de Sanctis L, Delmastro L, Russo MC, Matarazzo P, Lala R, de Sanctis C. Genetics of McCune-Albright syndrome. J Pediatr Endocrinol Metab. 2006; 19(suppl 2):577-582.
11. Diaz A, Danon M, Crawford J. McCune-Albright syndrome and disorders due to activating mutations of GNAS1. J Pediatr Endocrinol Metab. 2007;20(8): 853-880.
12. Lietman SA, Schwindinger WF, Levine MA. Genetic and molecular aspects of McCune-Albright syndrome. Pediatr Endocrinol Rev. 2007;4(suppl 4):380-385.
13. Sargin H, Gozu H, Bircan R, et al. A case of McCune-Albright syndrome associated with Gs alpha mutation in the bone tissue. Endocr J. 2006;53(1):35-44.
14. Imanaka M, Iida K, Nishizawa H, et al. McCune-Albright syndrome with acromegaly and fibrous dysplasia associated with the GNAS gene mutation identified by sensitive PNA-clamping method. Intern Med. 2007;46(18):1577-1583.
15. Pollandt K, Engels C, Kaiser E, Werner M, Delling G. Gs-alpha gene mutations in monostotic fibrous dysplasia of bone and fibrous dysplasia-like lowgrade central osteosarcoma. Virchows Arch. 2001;439(2):170-175.
16. Riminucci M, Robey PG, Bianco P. The pathology of fibrous dysplasia and the McCune-Albright syndrome. Pediatr Endocrinol Rev. 2007;4(suppl 4):401-411.
17. Regard JB, Cherman N, Palmer D, et al. WNT/b-catenin signaling is differentially regulated by Ga proteins and contributes to fibrous dysplasia. Proc Natl Acad Sci U S A. 2011;108(50):20101-20106.
18. DeMers NM, Schlauder SM, Bui MM. Immunostain patterns of HER-2, EGFR and CD117 in fibrous dysplasia: A six-case series and literature review. J Orthop. 2009;6(2):e4.
19. Dal Cin P, Sciot R, Speleman F, et al. Chromosome aberrations in fibrous dysplasia. Cancer Genet Cytogenet. 1994;77(2):114-117.
20. Ruggieri P, Sim FH, Bond JR, Unni KK. Malignancies in fibrous dysplasia. Cancer. 1994;73(5):1411-1424.
21. De Iure F, Campanacci L. Clinical and radiographic progression of fibrous dysplasia: Cystic change or sarcoma?: Description of a clinical case and review of the literature. Chir Organi Mov. 1995;80(1):85-89.
22. Doganavsargil B, Argin M, Kececi B, Sezak M, Sanli UA, Oztop F. Secondary osteosarcoma arising in fibrous dysplasia, case report. Arch Orthop Trauma Surg. 2009;129(4):439-444.
23. Hansen MR, Moffat JC. Osteosarcoma of the skull base after radiation therapy in a patient with McCune-Albright syndrome: Case report. Skull Base. 2003;13(2):79-83.
24. Healey JH, Buss D. Radiation and pagetic osteogenic sarcomas. Clin Orthop Relat Res. 1991;(270):128-134.
25. Jhala DN, Eltoum I, Carroll AJ, et al. Osteosarcoma in a patient with McCune-Albright syndrome and Mazabraud's syndrome: A case report emphasizing the cytological and cytogenetic findings. Hum Pathol. 2003;34(12):1354-1357.
26. DeMers Riddle NM, Yamauchi H, Caracciolo JT, et al. Chondrosarcoma arising in fibrous dysplasia: A case report and review of the current literature. Pathol Lab Med Int. 2009;1:1-6.
27. Hoshi M, Matsumoto S, Manabe J, et al. Malignant change secondary to fibrous dysplasia. Int J Clin Oncol. 2006;11(3):229-235.
28. Unni KK, Inwards C, Bridge JA, Kindblom L, Wold LE, eds. Tumors of the Bones and Joints. Silver Spring, MD: Armed Registry of Pathology, and Washington, DC: Armed Forces Institute of Pathology; 2006. Atlas of Tumor Pathology; 4th series, fascicle 2.
29. Bielack SS, Kempf-Bielack B, Heise U, Schwenzer D, Winkler K; Cooperative German-Austrian-Swiss Osteosarcoma Study Group. Combined modality treatment for osteosarcoma occurring as a second malignant disease. J Clin Oncol 1999;17(4):1164.